Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-066063
Filing Date
2014-11-07
Accepted
2014-11-07 16:04:21
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v392677_10q.htm 10-Q 541180
2 EXHIBIT 10.1 v392677_ex10-1.htm EX-10.1 322756
3 EXHIBIT 31.1 v392677_ex31-1.htm EX-31.1 11169
4 EXHIBIT 31.2 v392677_ex31-2.htm EX-31.2 11194
5 EXHIBIT 32.1 v392677_ex32-1.htm EX-32.1 5815
  Complete submission text file 0001144204-14-066063.txt   6191590

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ecyt-20140930.xml EX-101.INS 1157634
7 XBRL TAXONOMY EXTENSION SCHEMA ecyt-20140930.xsd EX-101.SCH 27245
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ecyt-20140930_cal.xml EX-101.CAL 29193
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ecyt-20140930_def.xml EX-101.DEF 180706
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ecyt-20140930_lab.xml EX-101.LAB 250095
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ecyt-20140930_pre.xml EX-101.PRE 218807
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 141204918
SIC: 2834 Pharmaceutical Preparations